Future New Indications for CRT: Which Patients Might Benefit?

  • B. Pezzulich
  • P. Greco Lucchina
Conference paper


Cardiac resynchronisation therapy (CRT) is a non-pharmacological treatment for patients with severe congestive heart failure (CHF) due to systolic dysfunction who also present an intraventricular conduction abnormality and a QRS duration greater than 120 ms [1]. CRT has been shown to improve functional status, quality of life, and exercise tolerance and to decrease hospitalisation frequency in these patients: recent results of the MUSTIC [2] and MIRACLE [3] trials are consistent in showing an improvement in NYHA class, quality of life scores, and distance covered during a 6-min walking test. A decrease in dynamic mitral regurgitation, increase in left ventricular ejection fraction, and reverse remodelling effect on the left ventricle has also been noted. The COMPANION study has recently demonstrated that CRT provides significantly better results regarding a combined endpoint of mortality and heart failure hospitalisation [4].

Consequently, CRT has been included in the current American Heart Association/American College of Cardiology/North American Society of Pacing and Electrophysiology guidelines for the implantation of permanent pacemakers as a therapeutic option for patients with systolic heart failure, NYHA class ≥ 3, QRS duration ≥ 130 ms, left ventricular end-diastolic diameter ≥ 55 mm and ejection fraction < 35% [5]. According to these criteria, between 13% and 35% of patients with heart failure would be eligible for CRT [6, 7]. However, a growing body of evidence seems to suggest that a larger proportion of heart failure patients could benefit of CRT. Some of the ‘new’ indications for CRT are discussed in this paper.


Mitral Regurgitation Cardiac Resynchronisation Therapy NYHA Class Heart Failure Hospitalisation Mechanical Dyssynchrony 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hlatky MA, Massie BM (2004) Cardiac resynchronization for heart failure. Ann Intern Med 141:409–410Google Scholar
  2. 2.
    Linde C, Leclercq C, Rex S et al (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite STimulation In Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 40:111–118PubMedCrossRefGoogle Scholar
  3. 3.
    Abraham WT, Fisher WG, Smith AL et al (2002). Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853PubMedCrossRefGoogle Scholar
  4. 4.
    Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150PubMedCrossRefGoogle Scholar
  5. 5.
    A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. American College of Cardiology website. Accessed October 12, 2002Google Scholar
  6. 6.
    Vardas PE, Simantirakis EN (2003) Resynchronization Therapy: Implications for Pacemaker Implantation in Europe. CEPR 7:27–29PubMedGoogle Scholar
  7. 7.
    Achilli A, Sassara M, Ficili S (2003) Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol 42:2117–2124PubMedCrossRefGoogle Scholar
  8. 8.
    Ghio S, Constantin C, Klersy C et al (2004) Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 25:571–578PubMedCrossRefGoogle Scholar
  9. 9.
    Yu CM, Lin H, Zhang Q et al (2003) High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 89:54–60PubMedCrossRefGoogle Scholar
  10. 10.
    Lamp B, Vogt J, Faber L et al (2004) Extended indications for cardiac resynchronization therapy? Eur Heart J 6(Suppl D): D128–D131Google Scholar
  11. 11.
    Yu CM, Lin H, Zhang Q et al (2003) High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 89:54–60PubMedCrossRefGoogle Scholar
  12. 12.
    Cleland JGF, Daubert JC, Erdmann E et al (2001) The CARE-HF study (CArdiac REsynchronisation in Heart Failure study ): rationale, design and end-points. Eur J Heart Fail 3:481–489PubMedCrossRefGoogle Scholar
  13. 13.
    Garrigue S, Reuter S, Labeque JN et al (2001) Usefulness of biventricular pacing in patients with congestive heart failure and right bundle branch block. Am J Cardiol 88:1436–1441PubMedCrossRefGoogle Scholar
  14. 14.
    Askenazi J, Alexander JH, Koenigsberg DI et al (1984) Alteration of left ventricular performance by left bundle block simulated with atrioventricular sequential pacing. Am J Cardiol 53:99–104PubMedCrossRefGoogle Scholar
  15. 15.
    Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937PubMedCrossRefGoogle Scholar
  16. 16.
    The DAVID trial investigators (2002) Dual chamber pacing or ventricular backup pacing in patient with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 288:3115–23CrossRefGoogle Scholar
  17. 17.
    Funck RC, Mueller HH, Schade-Brittinger C et al (2003) Rationale, design and end points of a clinical study on biventricular pacing for atrioventricular block in left ventricular dysfunction to prevent cardiac desynchronization—the BIOPACE study. Europace, Suppl B, P–167 (B106)Google Scholar
  18. 18.
    Baldessaroni S, De Biase L, Fresco C et al (2002) Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure. Eur Heart J 23:1692–1698Google Scholar
  19. 19.
    Nelson GS, Berger RD, Fetics BJ et al (2000) Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation 102:3053–3059PubMedGoogle Scholar
  20. 20.
    Young B, Abraham WT (2003) Cardiac resynchronization limits disease progression in patients with mild heart failure and an indication for ICD—results of a randomized study. Circulation 108:IV–629Google Scholar
  21. 21.
    Bristow MR, Feldman AM, Saxon LA et al (2003) Cardiac resynchronization therapy (CRT) reduces hospitalizations, and CRT with implantable defibrillator (CRT-D) reduces mortality in chronic heart failure: the COMPANION trial. Available at Accessed January 10Google Scholar

Copyright information

© Springer-Verlag Italia 2005

Authors and Affiliations

  • B. Pezzulich
    • 1
  • P. Greco Lucchina
    • 1
  1. 1.Cardiology DepartmentSan Luigi Gonzaga HospitalTurinItaly

Personalised recommendations